Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Longitudinal Research02:20

Longitudinal Research

11.9K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Censoring Survival Data01:09

Censoring Survival Data

65
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
65

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phylogenetic tree inference from single-cell RNA sequencing data with SCITE-RNA.

Genome biology·2026
Same author

Wastewater-based sequencing of respiratory syncytial virus to investigate lineage dynamics and antigenic site mutations: a retrospective genomic epidemiology study.

The Lancet. Microbe·2026
Same author

Learning and forecasting selection dynamics of SARS-CoV-2 variants from wastewater sequencing data using Covvfit.

Water research·2026
Same author

Goals and trends in space exploration: An overview of the panel on exploration sessions at the committee on space research general assembly 2024.

Life sciences in space research·2026
Same author

Corrigendum to "Characterizing Influenza A Virus Lineages and Clinically Relevant Mutations Through High-Coverage Wastewater Sequencing" [Water Research (2025) Article No. 124453].

Water research·2026
Same author

Unifying non-Markovian dynamics and agent heterogeneity in scalable stochastic networks.

Nature communications·2026
Same journal

GMSA: A Graph Matching and Point Cloud Registration-Based Method for Spatial Transcriptomics Data Alignment.

Journal of computational biology : a journal of computational molecular cell biology·2026
Same journal

Investigations on Multiple Protein Scaffold Filling.

Journal of computational biology : a journal of computational molecular cell biology·2026
Same journal

Cell Type Prediction for Single-Cell RNA Sequencing Utilizing Unsupervised Domain Adaptation and Semi-Supervised Learning.

Journal of computational biology : a journal of computational molecular cell biology·2026
Same journal

PPIGAN: Prediction of Protein-Protein Interactions Using Generative Adversarial Networks.

Journal of computational biology : a journal of computational molecular cell biology·2026
Same journal

Deep Structure-Enhanced Cell Clustering Model for Single-Cell RNA Sequencing Data.

Journal of computational biology : a journal of computational molecular cell biology·2026
Same journal

Asymmetric Drug-Drug Interaction Prediction Based on Generative Adversarial Networks and Knowledge Graph.

Journal of computational biology : a journal of computational molecular cell biology·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Correcting for Observation Bias in Cancer Progression Modeling.

Rudolf Schill1, Maren Klever2, Andreas Lösch3

  • 1Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.

Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|October 31, 2024
PubMed
Summary
This summary is machine-generated.

Cancer progression models can be biased by tumor detectability. This study corrects for this bias, revealing new causal links between genetic events in cancer progression and improving tumor detection rates for specific mutations.

Keywords:
cancer progression modelcollider biasselection bias

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

222

Related Experiment Videos

Last Updated: Jun 9, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

222

Area of Science:

  • Genomics
  • Cancer Biology
  • Computational Biology

Background:

  • Tumor progression involves genetic alterations, but their temporal sequence is hard to determine from static data.
  • Mutual Hazard Networks (MHNs) model cancer progression by analyzing co-occurrence of genetic events.
  • Cross-sectional cancer genomic data may contain a 'collider bias' due to clinical detection factors.

Purpose of the Study:

  • To identify and correct for collider bias in cancer progression modeling.
  • To enhance Mutual Hazard Networks (MHNs) by accounting for tumor detectability.
  • To uncover accurate causal interactions between genetic alterations during tumor development.

Main Methods:

  • Developed an enhanced MHN model incorporating genetic events' impact on tumor detectability.
  • Derived an efficient tensor formula for the likelihood function.
  • Applied the enhanced model to colon and lung adenocarcinoma datasets from the MSK-IMPACT study.

Main Results:

  • Identified significantly higher clinical detection rates for TP53-mutated colon adenocarcinoma.
  • Observed significantly higher clinical detection rates for EGFR-mutated lung adenocarcinoma.
  • The enhanced MHN approach corrected spurious suppressive interactions and revealed promoting effects.

Conclusions:

  • Collider bias significantly distorts cancer progression modeling from cross-sectional data.
  • Accounting for tumor detectability improves the accuracy of inferring genetic event interactions.
  • This enhanced modeling approach provides a more accurate understanding of cancer evolution and identifies key drivers.